Nymox Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2020
May 14, 2020 at 04:43 pm EDT
Nymox Pharmaceutical Corporation announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced total revenue was USD 5,000 compared to USD 30,000 a year ago. Operating loss was USD 2.631 million compared to USD 2.913 million a year ago. Net loss was USD 2.615 million compared to USD 2.870 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.04 a year ago.